OrbusNeich Medical Group Holdings Ltd
06929
Company Profile
Business description
OrbusNeich Medical Group Holdings Ltd is a China-based medical device maker of endovascular interventional instruments with majority reach. Its segment include: Asia Pacific region, except Japan and the PRC (APAC), Europe, Middle East & Africa (EMEA), Japan, The PRC, and United States, of which maximum revenue is derived from APAC.
Contact
3rd Floor, Building 20E
Units 303 and 305
Hong Kong Science Park
Shatin New Town
Hong Kong
HKGT: +852 28022288
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
1,432
Stocks News & Analysis
stocks
Overpriced ASX listed consumer electronics retailers
Solid balance sheets, lower business risk and strong sales but investors are overly optimistic.
stocks
Nvidia and AMD: Maintain fair value estimate amid reports of Meta’s negotiations to buy Google TPUs
Our update on select stocks from the Semiconductors industry.
stocks
Alphabet: Gemini momentum and possible Meta TPU deal underscore AI capability
We think Alphabet is exceptionally well positioned in everything AI.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,912.00 | 2.90 | 0.03% |
| CAC 40 | 8,099.47 | 3.04 | 0.04% |
| DAX 40 | 23,767.96 | 41.74 | 0.18% |
| Dow JONES (US) | 47,427.12 | 314.67 | 0.67% |
| FTSE 100 | 9,693.93 | 2.35 | 0.02% |
| HKSE | 25,945.93 | 17.85 | 0.07% |
| NASDAQ | 23,214.69 | 189.10 | 0.82% |
| Nikkei 225 | 50,167.10 | 608.03 | 1.23% |
| NZX 50 Index | 13,432.20 | 129.81 | -0.96% |
| S&P 500 | 6,812.61 | 46.73 | 0.69% |
| S&P/ASX 200 | 8,617.30 | 2.40 | 0.03% |
| SSE Composite Index | 3,875.26 | 11.08 | 0.29% |